Zinc, copper, manganese, and selenium metabolism in patients with human growth hormone deficiency or acromegaly.
This study was designed to evaluate trace metal metabolism in patients with known abnormalities of human growth hormone (hGH). The mean concentration of zinc in plasma and urine decreased in patients with hGH deficiency after hGH injection, whereas, after adenomectomy, in patients with acromegaly, zinc increased in plasma, remained the same in erythrocytes, and decreased in urine. There was a negative correlation between plasma zinc and serum hGH levels and a positive correlation between urinary zinc excretion and serum hGH levels in acromegaly. In hGH deficiency, the copper content remained unchanged in plasma and erythrocytes and rose in urine after treatment; however, in acromegaly, the copper content increased in plasma and remained unchanged in erythrocytes and urine after surgery. The mean concentration of erythrocyte manganese did not change significantly after treatment in patients with hGH deficiency or acromegaly, but the pre-hGH treatment level of erythrocyte manganese in hGH deficiency was lower than in the controls. Plasma selenium concentrations were decreased in hGH deficiency and increased in acromegaly patients after therapy. These results suggest that hGH affects the metabolism of zinc, copper, manganese, and selenium.
D000172:Acromegaly / Q000378:metabolism* / Q000601:surgery; D000293:Adolescent; D000328:Adult; D002648:Child; D003300:Copper / Q000378:metabolism*; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy / Q000378:metabolism*; D013006:Growth Hormone / Q000172:deficiency* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008345:Manganese / Q000378:metabolism*; D008875:Middle Aged; D012643:Selenium / Q000378:metabolism*; D015032:Zinc / Q000378:metabolism*
D008345:Manganese; D003300:Copper; D013006:Growth Hormone; D012643:Selenium; D015032:Zinc